Post-Marketing Safety Surveillance Should Include Data Mining, FDA Says

FDA proposes data mining as one technique useful for drawing connections between products and adverse events in a draft guidance on post-marketing safety surveillance

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet